– USA, OH – The Procter & Gamble Company (NYSE: PG) today announced the appointment of Ashley McEvoy to its Board of Directors, effective December 12, 2023.
“Ashley’s transformative leadership, track record of innovation and breadth of experience in serving consumers and growing markets will be an asset to P&G. Her expertise will further strengthen the capability of our Board as we improve the lives of consumers around the world,” said Chairman and CEO, Jon Moeller.
About Ashley McEvoy
During her nearly three-decade career with Johnson & Johnson, Ashley McEvoy most recently led its $27 billion Medical Devices segment, which is the world’s second-largest medical devices business. In this capacity, she spearheaded efforts to develop integrated, digitized solutions to improve outcomes for millions of people around the world. This includes having led the business’ entrance into telehealth, robotics, and digital surgery, and deployment of more than $20 billion in M&A activity in recent years to grow the business portfolio.
She previously served as Johnson & Johnson’s Group Chairman of consumer Medical Devices; Group Chairman of Vision Care; Worldwide President of Ethicon Products; President of McNeil Consumer Healthcare; and various management, marketing, and brand management roles in OTC and other consumer health care.
About Procter & Gamble
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always, Ambi Pur, Ariel, Bounty, Charmin, Crest, Dawn, Downy, Fairy, Febreze, Gain, Gillette, Head & Shoulders, Lenor, Olay, Oral-B, Pampers, Pantene, SK-II, Tide, Vicks, and Whisper. The P&G community includes operations in approximately 70 countries worldwide.
SOURCE: https://us.pg.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.